Quantitative Analysis of Epstein-Barr Virus DNA Load in Bone Marrow Transplant Recipients By Using Real-Time PCR
,
Abstract
Introduction: Quantification of Epstein - Barr virus (EBV) in peripheral blood mononuclear cells (PBMNC) of allogenic bone marrow transplant (BMT) recipients is important because EBV-associated posttransplant Lymphoproliferative disease (PTLD) can occur after transplantation due to immunosup-pression therapy.
Methods: To this end we chose Real-Time PCR using TaqMan probe. For the standard curve, we cloned BALF5 gene of EBV into a plasmid vector. After purification of the EBV-clone and calculation of plasmid copy number, the standard curve was constructed by using serial dilution of the plasmid clone.
Results: We were able to detect from 2 to 107 copies per 2×105 PBMNC with wide linear range. The mean EBV DNA copy number was 103.7 copies per 2×105 PBMNC. In this study, No patient of 35 BMT recipients (275 PBMNC samples) developed PTLD during five months follow up post transplant. EBV copy numbers in 22 samples (3 patients) out of 35 BMT recipients were higher than cut off value with symptoms like fever and pulomonary noddes (9%). The virus load in one patient in the last sample obtained was 72400 copies. We detected low levels of EBV DNA in 20 BMT patients (57/1%).
Conclusion: Real-Time PCR is useful to measure virus load in PBMNC. Detection of EBV in PBMNC samples may be valuable predictive marker to prognosis PTLD. Further studies need to determine ac-curate viral cut off value for treatment patients at risk for PTLD.
Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol. 2001; 1: 75 -82.
Au WU, Pang A, et al. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood. 2004; 104: 243-249.
Heslop HE, Roony CM. Adoptive cellular immunotherapy for EBV lymphoproliferative diseases. Immunol Rev. 1997; 157: 217-222.
Jabs WJ, Henning H, et al. Normalized quantification by Real-Time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders. J Clin Microbiol. 2001; 39: 564-569.
Bai XG, Hosler BB, et al. Quantitative polymeraise chain reaction for human herpes virus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder. Clin chem. 1997; 43: 1843 – 1849.
Lucas KG, Burton RL, et al. Semiquantitative Epstein- Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood. 1998; 91: 3654-3661.
Rowe DT, Reyes N, et al. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol. 1997; 35: 1612-1615.
Heid CA, Stevens KJ, et al. Real-Time quantitative PCR. Genome Res. 1996; 6: 986-994.
Kimura H, Morita M, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol. 1999; 37: 132-136.
Niesters HG, Van Esser J, Fries E, et al Development of a Real-Time quantiative assay for detection of Epstein - Barr virus. J. Clin. Microbiol. 2000; 38: 712- 715.
Curtis RE, Travis LB, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a Multiinstitutional study. Blood. 1999; 94: 2208-2216.
Vikas, D. Post-transplant lymphoproliferative disease, 2005.
Allen U, Tellier R, et al. Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease. 2001; 33: 145-151.
| Files | ||
| Issue | Vol 2, No 3 (2005) | |
| Section | Articles | |
| Keywords | ||
| Epstein - Barr virus (EBV) posttransplant Lymphoproliferative disease | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
